Spotlight On... WuXi partners up for genomics in China; Medidata stumbles in wire fraud case; and more...

Chinese CRO WuXi PharmaTech has teamed up with IT firm Huawei to develop a cloud-based data management platform to support the country's precision medicine initiative. The deal, through WuXi's NextCODE business, will match the CRO's expertise in genomics with Huawei's experience in building digital infrastructure, the companies said. More

> Clinical trial tech firms PointCross Life Sciences and Xybion are teaming up to market regulatory services to drugmakers ahead of a big shift in FDA rules. News

> A federal judge has refused to rule on a case stemming from the $4.8 million wire transfer fraud that was inflicted on Medidata ($MDSO) in 2014. Story

Suggested Articles

Data firm Syapse has begun working with the FDA to help bring real-world evidence to bear on the agency’s decisions to approve cancer drugs.

The People-Centered Research Foundation tapped Datavant to de-identify real-world data across its national clinical research network.

Boehringer Ingelheim and MD Anderson Cancer Center have joined forces to create a “virtual” R&D hub so the pair can work on cancer drugs.